Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Work productivity in rheumatoid arthritis patients from two Latin American countries treated with tofacitinib or biological DMARDs.
Gutierrez-Ardila MV, Reyes J, Madariaga H, Otero W, Guzman R, Izquierdo J, Abello M, Velez P, Castillo D, Ponce de Leon D, Lukic T, Amador L. Gutierrez-Ardila MV, et al. Among authors: amador l. Expert Rev Pharmacoecon Outcomes Res. 2022 Jul;22(5):787-794. doi: 10.1080/14737167.2022.2047935. Epub 2022 Mar 16. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 35249439
Impact of access to treatment on patient-reported outcomes among rheumatoid arthritis patients with tDMARDs and bDMARDS in two Latin-American countries: A prospective observational study.
Reyes JM, Gutierrez-Ardila MV, Madariaga H, Otero W, Guzman R, Izquierdo J, Del Castillo DJ, Abello M, Velez P, Ponce de Leon D, Lukic T, Amador LF, Castaño N. Reyes JM, et al. Among authors: amador lf. Health Sci Rep. 2023 Mar 3;6(3):e1034. doi: 10.1002/hsr2.1034. eCollection 2023 Mar. Health Sci Rep. 2023. PMID: 36875929 Free PMC article.
Patient-reported outcomes in RA patients treated with tofacitinib or bDMARDs in real-life conditions in two Latin American countries.
Reyes JM, Gutierrez MV, Madariaga H, Otero W, Guzman R, Izquierdo J, Abello M, Velez P, Castillo D, Ponce de Leon D, Lukic T, Amador L. Reyes JM, et al. Among authors: amador l. Reumatol Clin (Engl Ed). 2023 Jun-Jul;19(6):319-327. doi: 10.1016/j.reumae.2023.02.006. Reumatol Clin (Engl Ed). 2023. PMID: 37286268 Free article.
A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America.
Rangel-Patiño J, Lee-Tsai YL, Urbalejo-Ceniceros VI, Luna-Perez MEM, Espinosa-Bautista KA, Amador LF, Cabrera-García Á, Balderas-Delgado C, Inclan-Alarcon SI, Neme-Yunes Y, Sanchez-Albarrán JM, Apodaca EI, Meillon-García L, Stock W, Demichelis-Gómez R. Rangel-Patiño J, et al. Among authors: amador lf. Blood Adv. 2023 Sep 26;7(18):5202-5209. doi: 10.1182/bloodadvances.2023009754. Blood Adv. 2023. PMID: 37307212 Free PMC article.
Red List assessment of amphibian species of Ecuador: A multidimensional approach for their conservation.
Ortega-Andrade HM, Rodes Blanco M, Cisneros-Heredia DF, Guerra Arévalo N, López de Vargas-Machuca KG, Sánchez-Nivicela JC, Armijos-Ojeda D, Cáceres Andrade JF, Reyes-Puig C, Quezada Riera AB, Székely P, Rojas Soto OR, Székely D, Guayasamin JM, Siavichay Pesántez FR, Amador L, Betancourt R, Ramírez-Jaramillo SM, Timbe-Borja B, Gómez Laporta M, Webster Bernal JF, Oyagata Cachimuel LA, Chávez Jácome D, Posse V, Valle-Piñuela C, Padilla Jiménez D, Reyes-Puig JP, Terán-Valdez A, Coloma LA, Pérez Lara MB, Carvajal-Endara S, Urgilés M, Yánez Muñoz MH. Ortega-Andrade HM, et al. Among authors: amador l. PLoS One. 2021 May 6;16(5):e0251027. doi: 10.1371/journal.pone.0251027. eCollection 2021. PLoS One. 2021. PMID: 33956885 Free PMC article.
73 results